Lonza CEO Pierre-Alain Ruffieux to Leave
Lonza CEO Pierre-Alain Ruffieux to Leave
Read more
Tag: Pharmaceuticals
The Brash Strategy That Made Vivek Ramaswamy a Fortune
Updated Sept. 9, 2023 10:51 am ETVivek Ramaswamy was a novice biotech entrepreneur in 2016 with no advanced medical training ...
Read more
J&J Dividend Decision Shows Power of Free Cash Flow
Text size Johnson & Johnson Benadryl brand allergy medication is now a part of Kenvue. Daniel Acker/Bloomberg Johnson & Johnson ...
Read more
Rite Aid Prepares Bankruptcy That Would Halt Opioid Lawsuits
Resume Subscription We are delighted that you'd like to resume your subscription. You will be charged $ + tax (if ...
Read more
J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.
Text size Johnson & Johnson took the Kenvue consumer-health business public in May. Mark Ralston/Getty Images Johnson and Johnson ’s ...
Read more
JNJ Kenvue Exchange Offer Is Almost Here. What to Do Now.
Text size The Johnson & Johnson campus in Irvine, California. Mario Tama/Getty Images It’s crunchtime for investors in Johnson & ...
Read more
Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock.
Many individual investors are trying to do that by purchasing 99 shares of Johnson & Johnson to take advantage of ...
Read more
Eli Lilly Stock Jumps After Strong Earnings and Sales. Obesity Drugs Delivered.
Text size Analysts project that Mounjaro will be the best-selling drug of all time. Dreamstime Sales of Eli Lilly ‘s ...
Read more
J&J’s $40 Billion Kenvue Stock Swap: What You Need to Know
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or ...
Read more
Johnson & Johnson Rips Off the Kenvue Band-Aid
Johnson & Johnson Rips Off the Kenvue Band-Aid
Read more
